10-K - KORU Medical Systems, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

KORU Medical Systems reported FY 2025 net revenues of $41.1M, a 22.2% increase from $33.6M in FY 2024. Despite revenue growth, the company recorded a net loss of $2.6M, a significant improvement from the $6.1M net loss in the prior year. Gross profit increased to $25.6M with a gross margin of 62.3%, up from 63.4% in FY 2024. Operating expenses totaled $28.6M, with R&D spending decreasing to $4.4M from $5.3M. The company generated positive operating cash flow of $462K, though cash decreased by $709K due to investing activities. Key drivers included domestic revenue growth to $30.2M (up 9.9%) and international revenue growth to $10.9M (up 77.4%). The company maintains $8.9M in cash with total assets of $28.2M and stockholders' equity of $17.0M.

Key Takeaways

1Revenue grew 22.2% to $41.1M with international sales increasing 77.4% to $10.9M

2Net loss improved to $2.6M from $6.1M, a 57% reduction year-over-year

3Gross margin declined to 62.3% from 63.4% despite gross profit increasing to $25.6M

4Operating cash flow turned positive at $462K after negative $320K in prior year

5R&D spending decreased to $4.4M from $5.3M while SG&A increased to $23.4M

Key Financial Metrics

Revenue

$41.1M

+22.2%

Net Income

-$2.6M

+56.5%

Gross Margin

62.3%

63.4% prior year

Gross Profit

$25.6M

+20.0%

Business Segments

DomesticUS and Canada core product revenue

$30.2M+9.9% YoY

InternationalCore product revenue outside US and Canada

$10.9M+77.4% YoY